Achievements

Achievements

競争的資金
【研究代表者】小坂健
【研究資金】厚労科研：循環器疾患・糖尿病等生活習慣病対策総合研究事業 [2023-2024]
大規模コホートとリアルワールドデータを用いた口腔と全身疾患の関連についての研究
【研究代表者】福田治久
【研究資金】AMED：循環器疾患・糖尿病等生活習慣病対策実用化研究開発事業 [2022-2024]
高血圧発症予防に向けた先制保健介入モデルの開発
【研究代表者】福田治久
【研究資金】JST：創発的研究支援事業 [2021-2027]
健康データ創発的多地域コホート研究基盤の構築
【研究代表者】福田治久
【研究資金】AMED：ワクチン開発推進事業 [2021-2023]
保健・医療・介護・行政データを統合した大規模データベースを活用したワクチンの有効性・安全性の検証に資する研究開発
【研究代表者】福田治久
【研究資金】文部科研：基盤研究（A） [2020-2023]
レセプトデータを基軸としたデータ駆動型臨床疫学研究の基盤開発
【研究代表者】福田治久
【研究資金】AMED：長寿科学研究開発事業 [2020-2022]
ICTプラットホーム構築による介護予防サービスの実証フィールドの開発研究
【研究代表者】福田治久
【研究資金】文部科研：挑戦的研究（萌芽） [2019-2022]
地域住民の健康評価プラットフォームの開発と予防的保健医療介護事業の効果検証
【研究代表者】福田治久
【研究資金】厚労科研：長寿科学政策研究事業 [2019-2020]
エビデンスを踏まえた効果的な介護予防の実施に資する介護予防マニュアルの改訂のための研究
【研究代表者】竹内研時
【研究資金】文部科研：基盤研究（B） [2022-2026]
ビッグデータ活用による健康寿命延伸と医療・介護費抑制に資する口腔のエビデンス創出
【研究代表者】藤本雅大
【研究資金】文部科研：基盤研究（B） [2022-2025]
起立・歩行動作解析を基軸とした要介護リスク診断プラットフォームの創出
More
原著論文
Okui T*, Fukushima H, Maeda M, Oda F, Nakashima N, Fukuda H.
A short-term association between hospitalizations for mental disorders and ambient temperature in Japan: an ecological study using the LIFE Study data.
Environmental Health and Preventive Medicine 2026; 31: 12.
Shida H, Hirayama A, Kitamura T, Maeda M, Oda F, Fukuda H, Kawasaki R*.
Association between the care need level before admission and long-term outcomes in elderly patients with stroke: The Longevity Improvement & Fair Evidence (LIFE) study.
Journal of the American Medical Directors Association 2026; 27: 106165.
Kawaguchi K, Maeda M, Oda F, Nakashima Y, Fukuda H*.
Development and validation of a machine learning model for frailty screening using claims data in Japan: the Longevity Improvement & Fair Evidence Study.
Experimental Gerontology 2026; 215(2026): 113050.
Nakatsuka K, Ono R, Maeda M, Murata F, Fukuda H.
Long-term habitual physical activity and risk of mortality and long-term care insurance certification in cancer survivors: a prospective cohort study in the LIFE Study, Japan.
BMJ Open 2026; 16: e104102.
Sung Y, Goto K*, Akeno Y, Maeda M, Murata F, Fukuda H.
Sleep maintenance efficiency measured by multi-sensor wristband devices and its association with blood pressure: the LIFE Study.
Digital Health 2026; 12: 205520762614208752026.
Kawaguchi K, Maeda M, Oda F, Nakashima Y, Fukuda H*.
Initial real-world experience with lecanemab prescribing patterns in Japan: the Longevity Improvement & Fair Evidence (LIFE) Study.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2026: 18(1):e70273.
Katsuta T*, Sato S, Kawazoe Y, Fukuda H.
Active vaccine safety monitoring system using health insurance claims data in Japan: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.
Vaccine 2026; 74: 128209.
Sagara K, Goto K*, Maeda M, Oda F, Fukuda H.
Antihypertensive medication adherence and associated factors in older adults requiring long-term care: The LIFE Study.
Age and Ageing 2026; 55: afag018.
Kawazoe Y*, Katsuta T, Tanaka T, Nakamura Y, Sato S, Maeda M, Oda F, Fukuda H.
Prevalence of HPV Vaccine–Associated Symptoms in Unvaccinated Japanese Adolescents: A Descriptive Study from the VENUS Study Database.
Vaccine 2026; 70: 128020.
Sazawa M, Ishiguro C, Mimura W, Maeda M, Murata F, Fukuda H.
Impact of the resumption of proactive recommendation of HPV vaccination on HPV vaccination rates in Japan: An interrupted time series analysis based on the VENUS Study.
BMJ Public Health 2025; 3: e000982.
More
学会発表
Ogata H, Maeda M, Oda F, Okamoto I, Fukuda H.
Real-World Evaluation of Medication Adherence to Single-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease: The LIFE Study.
American Thoracic Society Conference 2026. 2026年5月17-20日. Orland.
Maeda H, Toizumi M, Igarashi A, Maeda M, Oda F, Fukuda H.
Incidence of COVID-19 Hospitalization and Seizures by Vaccination in Youth in Japan: VENUS Study.
The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, Nagasaki, January 28-30, 2026.
Zha L, Kimura Y, Komatsu M, Shimomura Y, Gon Y, Maeda M, Oda F, Komukai S, Kiyohara K, Kitamura T, Fukuda H.
Association of PPSV23 with Parkinson’s and Alzheimer’s Disease Risk: The VENUS Study.
The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, Nagasaki, January 28-30, 2026.
Sung Y, Goto K, Maeda M, Oda F, Fukuda H.
Bias in vaccination coverage from incomplete in-migrant records in Japan: the VENUS Study.
The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, Nagasaki, January 28-30, 2026.
Chikamochi S, Mimura W, Ishiguro C, Oda F, Maeda M, Fukuda H.
Effect of missing Enrollment Registry on Vaccine Effectiveness based on NDB’s feature: VENUS Study.
The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, NagasakiJanuary 28-30, 2026.
Kono Y, Ishiguro C, Hagiwara Y, Fukuda H, Takeuchi Y.
Selection bias in the test-negative case-control design.
The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, Nagasaki, January 28-30, 2026.
Kawaguchi K, Maeda M, Oda F, Nakashima Y, Fukuda H.
Initial real-world experience with lecanemab prescribing pattern in Japan: The LIFE Study.
The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, Nagasaki January 28-30, 2026.
秋山智紀, 平田明恵, 高橋富美, 前田恵, 小田太史, 中島直樹, 福田治久.
LIFE studyデータベースを用いた日本人集団におけるセレコキシブと心血管疾患リスクとの関連検討.
第10回日本糖尿病・生活習慣病ヒューマンデータ学会年次学術集会. 2025年12月13日-14日. 奈良.
Nishimura S, Kumamaru T, Maeda M, Oda F, Fukuda H.
Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Older Adults : the VENUS Study.
ISPE's 17th Asian Conference on Pharmacoepidemiology (ACPE) Hong Kong, China. 21-23 November 2025.
Arai K, Ishiguro C, Mimura W, Maeda M, Oda F, Fukuda H.
Examining the necessity of subgroup-based Rapid Cycle Analysis: Lessons from COVID-19 vaccine.
ISPE's 17th Asian Conference on Pharmacoepidemiology (ACPE) Hong Kong, China.21-23 November 2025.
More